Loading…
Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia
Background Achalasia is characterized by esophageal aperistalsis and impaired relaxation of the lower esophageal sphincter (LES). This contrasts with an insufficient LES, predisposing to gastro-esophageal reflux and Barrett’s esophagus. The co-incidence of achalasia and BE is rare. Pneumatic dilatat...
Saved in:
Published in: | Digestive diseases and sciences 2013, Vol.58 (1), p.244-252 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3 |
container_end_page | 252 |
container_issue | 1 |
container_start_page | 244 |
container_title | Digestive diseases and sciences |
container_volume | 58 |
creator | Leeuwenburgh, I. Scholten, P. Caljé, T. J. Vaessen, R. J. Tilanus, H. W. Hansen, B. E. Kuipers, E. J. |
description | Background
Achalasia is characterized by esophageal aperistalsis and impaired relaxation of the lower esophageal sphincter (LES). This contrasts with an insufficient LES, predisposing to gastro-esophageal reflux and Barrett’s esophagus. The co-incidence of achalasia and BE is rare. Pneumatic dilatation (PD) may lead to gastro-esophageal reflux, Barrett’s esophagus development, and esophageal adenocarcinoma.
Aims
To determine the incidence of Barrett’s esophagus and esophageal adenocarcinoma in achalasia patients treated with PD.
Methods
We performed a single-center cohort follow-up study of 331 achalasia patients treated with PD. Mean follow-up was 8.9 years, consisting of regular esophageal manometry, timed barium esophagram, and endoscopy.
Results
Twenty-eight (8.4 %) patients were diagnosed with Barrett’s esophagus, one at baseline endoscopy. This corresponds with an annual incidence of Barrett’s esophagus of 1.00 % (95 % CI 0.62–1.37). Hiatal herniation was present in 74 patients and 21 developed Barrett’s esophagus compared to seven of 257 patients without a hiatal hernia. Statistical analysis revealed a hazard ratio of 8.04 to develop Barrett’s esophagus if a hiatal hernia was present. Post-treatment LES pressures were lower in patients with Barrett’s esophagus than in those without (13.9 vs. 17.4 mmHg;
p
= 0.03). Two (0.6 %) patients developed esophageal adenocarcinoma during follow-up.
Conclusions
Barrett’s esophagus is incidentally diagnosed in untreated achalasia patients despite high LES pressures, but is more common after successful treatment, especially in the presence of hiatal herniation. Patients treated for achalasia should be considered for GERD treatment and surveillance of development of Barrett’s esophagus, in particular, when they have low LES pressures and a hiatal herniation. |
doi_str_mv | 10.1007/s10620-012-2157-9 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1942216925</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A712946901</galeid><sourcerecordid>A712946901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3</originalsourceid><addsrcrecordid>eNqFkc1u1TAQhS1ERS-FB2CDLLFhk-JxYjtehqvyI1Vic5eVLMeZ3KZK7IudLNjxGrweT4LDbcuPQJUX47G_czSjQ8gLYOfAmHqTgEnOCga84CBUoR-RTa5lwYWsH5MNA5nvAPKUPE3phjGmFcgn5JSXoDRUfEOu3toYcZ6_f_2W6EUKh2u7XxK1vrvr0I606dAHZ6MbfJgsbSLSbZim4GnTzxjpLqKdJ_Qz7UOkjbu2o02DfUZOejsmfH5bz8ju3cVu-6G4_PT-47a5LFyl-Fygcx0rmXZSCVe1UkJZVayrOWop-rZtlVLgXC36DpWoUUjBKs7z_NgywPKMvD7aHmL4vGCazTQkh-NoPYYlGdArLTUXD6O85nWpJYeMvvoLvQlL9HmPnxQvWaXlL2pvRzSD78McrVtNTaOA60pqtnqd_4PKp8NpcMFjP-T3PwRwFLgYUorYm0McJhu_GGBmzd4cszc5e7Nmb3TWvLwdeGkn7O4Vd2FngB-BlL_8HuNvG_3X9Qc4braz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1282230496</pqid></control><display><type>article</type><title>Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia</title><source>Springer Nature</source><creator>Leeuwenburgh, I. ; Scholten, P. ; Caljé, T. J. ; Vaessen, R. J. ; Tilanus, H. W. ; Hansen, B. E. ; Kuipers, E. J.</creator><creatorcontrib>Leeuwenburgh, I. ; Scholten, P. ; Caljé, T. J. ; Vaessen, R. J. ; Tilanus, H. W. ; Hansen, B. E. ; Kuipers, E. J.</creatorcontrib><description>Background
Achalasia is characterized by esophageal aperistalsis and impaired relaxation of the lower esophageal sphincter (LES). This contrasts with an insufficient LES, predisposing to gastro-esophageal reflux and Barrett’s esophagus. The co-incidence of achalasia and BE is rare. Pneumatic dilatation (PD) may lead to gastro-esophageal reflux, Barrett’s esophagus development, and esophageal adenocarcinoma.
Aims
To determine the incidence of Barrett’s esophagus and esophageal adenocarcinoma in achalasia patients treated with PD.
Methods
We performed a single-center cohort follow-up study of 331 achalasia patients treated with PD. Mean follow-up was 8.9 years, consisting of regular esophageal manometry, timed barium esophagram, and endoscopy.
Results
Twenty-eight (8.4 %) patients were diagnosed with Barrett’s esophagus, one at baseline endoscopy. This corresponds with an annual incidence of Barrett’s esophagus of 1.00 % (95 % CI 0.62–1.37). Hiatal herniation was present in 74 patients and 21 developed Barrett’s esophagus compared to seven of 257 patients without a hiatal hernia. Statistical analysis revealed a hazard ratio of 8.04 to develop Barrett’s esophagus if a hiatal hernia was present. Post-treatment LES pressures were lower in patients with Barrett’s esophagus than in those without (13.9 vs. 17.4 mmHg;
p
= 0.03). Two (0.6 %) patients developed esophageal adenocarcinoma during follow-up.
Conclusions
Barrett’s esophagus is incidentally diagnosed in untreated achalasia patients despite high LES pressures, but is more common after successful treatment, especially in the presence of hiatal herniation. Patients treated for achalasia should be considered for GERD treatment and surveillance of development of Barrett’s esophagus, in particular, when they have low LES pressures and a hiatal herniation.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1007/s10620-012-2157-9</identifier><identifier>PMID: 23179142</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Adenocarcinoma ; Adenocarcinoma - etiology ; Adult ; Aged ; Aged, 80 and over ; Analysis ; Barium ; Barrett Esophagus - etiology ; Biochemistry ; Development and progression ; Drug therapy ; Esophageal Achalasia - complications ; Esophageal diseases ; Esophageal Neoplasms - etiology ; Female ; Follow-Up Studies ; Gastroenterology ; Gastrointestinal agents ; Health aspects ; Hepatology ; Hernia ; Histamine H2 Antagonists ; Humans ; Male ; Medical research ; Medicine ; Medicine & Public Health ; Medicine, Experimental ; Middle Aged ; Oncology ; Original Article ; Pneumoviridae ; Proton Pump Inhibitors ; Transplant Surgery ; Treatment Outcome</subject><ispartof>Digestive diseases and sciences, 2013, Vol.58 (1), p.244-252</ispartof><rights>Springer Science+Business Media New York 2012</rights><rights>COPYRIGHT 2013 Springer</rights><rights>Springer Science+Business Media, LLC 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3</citedby><cites>FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23179142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leeuwenburgh, I.</creatorcontrib><creatorcontrib>Scholten, P.</creatorcontrib><creatorcontrib>Caljé, T. J.</creatorcontrib><creatorcontrib>Vaessen, R. J.</creatorcontrib><creatorcontrib>Tilanus, H. W.</creatorcontrib><creatorcontrib>Hansen, B. E.</creatorcontrib><creatorcontrib>Kuipers, E. J.</creatorcontrib><title>Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><addtitle>Dig Dis Sci</addtitle><description>Background
Achalasia is characterized by esophageal aperistalsis and impaired relaxation of the lower esophageal sphincter (LES). This contrasts with an insufficient LES, predisposing to gastro-esophageal reflux and Barrett’s esophagus. The co-incidence of achalasia and BE is rare. Pneumatic dilatation (PD) may lead to gastro-esophageal reflux, Barrett’s esophagus development, and esophageal adenocarcinoma.
Aims
To determine the incidence of Barrett’s esophagus and esophageal adenocarcinoma in achalasia patients treated with PD.
Methods
We performed a single-center cohort follow-up study of 331 achalasia patients treated with PD. Mean follow-up was 8.9 years, consisting of regular esophageal manometry, timed barium esophagram, and endoscopy.
Results
Twenty-eight (8.4 %) patients were diagnosed with Barrett’s esophagus, one at baseline endoscopy. This corresponds with an annual incidence of Barrett’s esophagus of 1.00 % (95 % CI 0.62–1.37). Hiatal herniation was present in 74 patients and 21 developed Barrett’s esophagus compared to seven of 257 patients without a hiatal hernia. Statistical analysis revealed a hazard ratio of 8.04 to develop Barrett’s esophagus if a hiatal hernia was present. Post-treatment LES pressures were lower in patients with Barrett’s esophagus than in those without (13.9 vs. 17.4 mmHg;
p
= 0.03). Two (0.6 %) patients developed esophageal adenocarcinoma during follow-up.
Conclusions
Barrett’s esophagus is incidentally diagnosed in untreated achalasia patients despite high LES pressures, but is more common after successful treatment, especially in the presence of hiatal herniation. Patients treated for achalasia should be considered for GERD treatment and surveillance of development of Barrett’s esophagus, in particular, when they have low LES pressures and a hiatal herniation.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma - etiology</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis</subject><subject>Barium</subject><subject>Barrett Esophagus - etiology</subject><subject>Biochemistry</subject><subject>Development and progression</subject><subject>Drug therapy</subject><subject>Esophageal Achalasia - complications</subject><subject>Esophageal diseases</subject><subject>Esophageal Neoplasms - etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gastroenterology</subject><subject>Gastrointestinal agents</subject><subject>Health aspects</subject><subject>Hepatology</subject><subject>Hernia</subject><subject>Histamine H2 Antagonists</subject><subject>Humans</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Medicine, Experimental</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Pneumoviridae</subject><subject>Proton Pump Inhibitors</subject><subject>Transplant Surgery</subject><subject>Treatment Outcome</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1TAQhS1ERS-FB2CDLLFhk-JxYjtehqvyI1Vic5eVLMeZ3KZK7IudLNjxGrweT4LDbcuPQJUX47G_czSjQ8gLYOfAmHqTgEnOCga84CBUoR-RTa5lwYWsH5MNA5nvAPKUPE3phjGmFcgn5JSXoDRUfEOu3toYcZ6_f_2W6EUKh2u7XxK1vrvr0I606dAHZ6MbfJgsbSLSbZim4GnTzxjpLqKdJ_Qz7UOkjbu2o02DfUZOejsmfH5bz8ju3cVu-6G4_PT-47a5LFyl-Fygcx0rmXZSCVe1UkJZVayrOWop-rZtlVLgXC36DpWoUUjBKs7z_NgywPKMvD7aHmL4vGCazTQkh-NoPYYlGdArLTUXD6O85nWpJYeMvvoLvQlL9HmPnxQvWaXlL2pvRzSD78McrVtNTaOA60pqtnqd_4PKp8NpcMFjP-T3PwRwFLgYUorYm0McJhu_GGBmzd4cszc5e7Nmb3TWvLwdeGkn7O4Vd2FngB-BlL_8HuNvG_3X9Qc4braz</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Leeuwenburgh, I.</creator><creator>Scholten, P.</creator><creator>Caljé, T. J.</creator><creator>Vaessen, R. J.</creator><creator>Tilanus, H. W.</creator><creator>Hansen, B. E.</creator><creator>Kuipers, E. J.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>2013</creationdate><title>Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia</title><author>Leeuwenburgh, I. ; Scholten, P. ; Caljé, T. J. ; Vaessen, R. J. ; Tilanus, H. W. ; Hansen, B. E. ; Kuipers, E. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma - etiology</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis</topic><topic>Barium</topic><topic>Barrett Esophagus - etiology</topic><topic>Biochemistry</topic><topic>Development and progression</topic><topic>Drug therapy</topic><topic>Esophageal Achalasia - complications</topic><topic>Esophageal diseases</topic><topic>Esophageal Neoplasms - etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gastroenterology</topic><topic>Gastrointestinal agents</topic><topic>Health aspects</topic><topic>Hepatology</topic><topic>Hernia</topic><topic>Histamine H2 Antagonists</topic><topic>Humans</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Medicine, Experimental</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Pneumoviridae</topic><topic>Proton Pump Inhibitors</topic><topic>Transplant Surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leeuwenburgh, I.</creatorcontrib><creatorcontrib>Scholten, P.</creatorcontrib><creatorcontrib>Caljé, T. J.</creatorcontrib><creatorcontrib>Vaessen, R. J.</creatorcontrib><creatorcontrib>Tilanus, H. W.</creatorcontrib><creatorcontrib>Hansen, B. E.</creatorcontrib><creatorcontrib>Kuipers, E. J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leeuwenburgh, I.</au><au>Scholten, P.</au><au>Caljé, T. J.</au><au>Vaessen, R. J.</au><au>Tilanus, H. W.</au><au>Hansen, B. E.</au><au>Kuipers, E. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia</atitle><jtitle>Digestive diseases and sciences</jtitle><stitle>Dig Dis Sci</stitle><addtitle>Dig Dis Sci</addtitle><date>2013</date><risdate>2013</risdate><volume>58</volume><issue>1</issue><spage>244</spage><epage>252</epage><pages>244-252</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Background
Achalasia is characterized by esophageal aperistalsis and impaired relaxation of the lower esophageal sphincter (LES). This contrasts with an insufficient LES, predisposing to gastro-esophageal reflux and Barrett’s esophagus. The co-incidence of achalasia and BE is rare. Pneumatic dilatation (PD) may lead to gastro-esophageal reflux, Barrett’s esophagus development, and esophageal adenocarcinoma.
Aims
To determine the incidence of Barrett’s esophagus and esophageal adenocarcinoma in achalasia patients treated with PD.
Methods
We performed a single-center cohort follow-up study of 331 achalasia patients treated with PD. Mean follow-up was 8.9 years, consisting of regular esophageal manometry, timed barium esophagram, and endoscopy.
Results
Twenty-eight (8.4 %) patients were diagnosed with Barrett’s esophagus, one at baseline endoscopy. This corresponds with an annual incidence of Barrett’s esophagus of 1.00 % (95 % CI 0.62–1.37). Hiatal herniation was present in 74 patients and 21 developed Barrett’s esophagus compared to seven of 257 patients without a hiatal hernia. Statistical analysis revealed a hazard ratio of 8.04 to develop Barrett’s esophagus if a hiatal hernia was present. Post-treatment LES pressures were lower in patients with Barrett’s esophagus than in those without (13.9 vs. 17.4 mmHg;
p
= 0.03). Two (0.6 %) patients developed esophageal adenocarcinoma during follow-up.
Conclusions
Barrett’s esophagus is incidentally diagnosed in untreated achalasia patients despite high LES pressures, but is more common after successful treatment, especially in the presence of hiatal herniation. Patients treated for achalasia should be considered for GERD treatment and surveillance of development of Barrett’s esophagus, in particular, when they have low LES pressures and a hiatal herniation.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>23179142</pmid><doi>10.1007/s10620-012-2157-9</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-2116 |
ispartof | Digestive diseases and sciences, 2013, Vol.58 (1), p.244-252 |
issn | 0163-2116 1573-2568 |
language | eng |
recordid | cdi_proquest_miscellaneous_1942216925 |
source | Springer Nature |
subjects | Adenocarcinoma Adenocarcinoma - etiology Adult Aged Aged, 80 and over Analysis Barium Barrett Esophagus - etiology Biochemistry Development and progression Drug therapy Esophageal Achalasia - complications Esophageal diseases Esophageal Neoplasms - etiology Female Follow-Up Studies Gastroenterology Gastrointestinal agents Health aspects Hepatology Hernia Histamine H2 Antagonists Humans Male Medical research Medicine Medicine & Public Health Medicine, Experimental Middle Aged Oncology Original Article Pneumoviridae Proton Pump Inhibitors Transplant Surgery Treatment Outcome |
title | Barrett’s Esophagus and Esophageal Adenocarcinoma Are Common After Treatment for Achalasia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A22%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Barrett%E2%80%99s%20Esophagus%20and%20Esophageal%20Adenocarcinoma%20Are%20Common%20After%20Treatment%20for%20Achalasia&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=Leeuwenburgh,%20I.&rft.date=2013&rft.volume=58&rft.issue=1&rft.spage=244&rft.epage=252&rft.pages=244-252&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1007/s10620-012-2157-9&rft_dat=%3Cgale_proqu%3EA712946901%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c472t-eccd0309c675c4b6613440d82e965fbbb7771cc85fde758e5650422142eb01e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1282230496&rft_id=info:pmid/23179142&rft_galeid=A712946901&rfr_iscdi=true |